[HTML][HTML] Updated view on kidney transplant from Hcv-infected donors and daas
F Fabrizi, R Cerutti, CM Alfieri, P Messa - Pharmaceutics, 2021 - mdpi.com
Background: The discrepancy between the number of potential available kidneys and the
number of patients listed for kidney transplant continues to widen all over the world. The …
number of patients listed for kidney transplant continues to widen all over the world. The …
[HTML][HTML] 'Real-life'experience with direct-acting antiviral agents for HCV after kidney transplant
F Fabrizi, C Alonso, A Palazzo, M Anders… - Annals of …, 2021 - Elsevier
Abstract Introductions and Objectives The introduction of direct-acting antiviral (DAA) agents
promises to change dramatically the management of hepatitis C in kidney transplant …
promises to change dramatically the management of hepatitis C in kidney transplant …
Replicating the effect of brain stimulation on mind wandering: A pre-registered study
A Alexandersen - 2022 - munin.uit.no
Mind wandering (MW) is a common mental phenomenon. Despite this, there is still much we
don't know about this pervasive mental state. Transcranial direct current stimulation (tDCS) …
don't know about this pervasive mental state. Transcranial direct current stimulation (tDCS) …
'Real-life'experience with direct-acting antiviral agents for HCV after kidney transplant
M Mendizabal, M Silva, F Fabrizi - 2021 - riu.austral.edu.ar
Introductions and objectives: The introduction of direct-acting antiviral (DAA) agents
promises to change dramatically the management of hepatitis C in kidney transplant …
promises to change dramatically the management of hepatitis C in kidney transplant …
[PDF][PDF] Medicina Digital
R Rangel-Aldao, A Martí-Carvajal - researchgate.net
En la Venezuela que inicia su tercera década del siglo XXI donde el impacto del modelo
político-ideológico impuesto, ha sido devastador para la institucionalidad democrática, en …
político-ideológico impuesto, ha sido devastador para la institucionalidad democrática, en …
[BOOK][B] Agentes biológicos en el tratamiento de enfermedades hematológicas malignas: revisiones sistemáticas
AJ Martí Carvajal - 2015 - ddd.uab.cat
Antecedentes: las enfermedades hematológicas malignas son un grupo variopinto de
neoplasias del sistema hematopoyético. Pueden ser agudas o crónicas; con desiguales …
neoplasias del sistema hematopoyético. Pueden ser agudas o crónicas; con desiguales …